Wedbush Raised Price Target on Medtronic (MDT) Following FY16 Guidance; Maintains Neutral

Go back to Wedbush Raised Price Target on Medtronic (MDT) Following FY16 Guidance; Maintains Neutral

Medtronic (MDT) PT Bumped to $91 at Needham & Company Post Q4

June 2, 2015 1:08 PM EDT

Needham & Company analyst Mike Matson reiterated a Buy rating and bumped his price target on Medtronic, Inc. (NYSE: MDT) to $91.00 (from $90.00) following Q4 results.

Analyst Matson commented, "MDT's F4Q15 revenue was consistent with its 5/20/15 preannouncement while its EPS came in ahead of... More

Medtronic (MDT) Tops Q4 EPS by 6c; Sees Larger FX Impact in FY16

June 2, 2015 7:24 AM EDT

Medtronic (NYSE: MDT) reported Q4 EPS of $1.16, $0.06 better than the analyst estimate of $1.10. Revenue for the quarter came in at $7.3 billion versus the consensus estimate of $7.14 billion.

The company today provided its fiscal year 2016 revenue outlook and diluted cash earnings per share (EPS)... More

Trading Radar for 6/2: Guess? (GES), Dollar General (DG), Violin Memory (VMEM), Ambarella (AMBA) Report

June 1, 2015 1:53 PM EDT

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Earnings:

American Woodmark (Nasdaq: AMWD) - consensus EPS $0.57
Conn's (Nasdaq: CONN) - consensus EPS $0.44... More